Multicenter study of lumen-apposing metal stents with or without pigtail in endoscopic ultrasound-guided biliary drainage for malignant obstruction—BAMPI TRIAL: an open-label, randomized controlled trial protocol
Albert Garcia-Sumalla,
Carme Loras,
Vicente Sanchiz,
Rafael Pedraza Sanz,
Enrique Vazquez-Sequeiros,
Jose Ramon Aparicio,
Carlos de la Serna-Higuera,
Daniel Luna-Rodriguez,
Xavier Andujar,
María Capilla,
Tatiana Barberá,
Jose Ramon Foruny-Olcina,
Belen Martínez,
Miguel Dura,
Silvia Salord,
Berta Laquente,
Cristian Tebe,
Sebastia Videla,
Manuel Perez-Miranda,
Joan B. Gornals,
On behalf of Spanish Working Group on Endoscopic Ultrasound Guided Biliary Drainage
Affiliations
Albert Garcia-Sumalla
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL)
Carme Loras
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari Mútua Terrassa, Fundació per la Recerca Mútua Terrassa, CIBERehd
Vicente Sanchiz
Endoscopy Unit, Department of Digestive Diseases, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA
Rafael Pedraza Sanz
Endoscopy Unit, Department of Digestive Diseases Endoscopy Unit, Hospital General Universitario de Castellón
Enrique Vazquez-Sequeiros
Endoscopy Unit, Gastroenterology and Hepatology Service, Hospital Ramon y Cajal, IRYCIS
Jose Ramon Aparicio
Endoscopy Unit, Department of Digestive Diseases, Hospital General Universitario de Alicante; Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL)
Carlos de la Serna-Higuera
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitario Rio Hortega
Daniel Luna-Rodriguez
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL)
Xavier Andujar
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari Mútua Terrassa, Fundació per la Recerca Mútua Terrassa, CIBERehd
María Capilla
Endoscopy Unit, Department of Digestive Diseases, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA
Tatiana Barberá
Endoscopy Unit, Department of Digestive Diseases Endoscopy Unit, Hospital General Universitario de Castellón
Jose Ramon Foruny-Olcina
Endoscopy Unit, Gastroenterology and Hepatology Service, Hospital Ramon y Cajal, IRYCIS
Belen Martínez
Endoscopy Unit, Department of Digestive Diseases, Hospital General Universitario de Alicante; Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL)
Miguel Dura
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitario Rio Hortega
Silvia Salord
Hepato-Bilio-Pancreatic Unit, Digestive Diseases Department, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL)
Berta Laquente
Clinical Oncology Department, Hospital Duran y Reynalds, Institu Oncologic de Catalunya
Cristian Tebe
Bellvitge Biomedical Research Institute (IDIBELL)
Sebastia Videla
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL)
Manuel Perez-Miranda
Endoscopy Unit, Department of Digestive Diseases, Hospital General Universitario de Alicante; Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL)
Joan B. Gornals
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL)
On behalf of Spanish Working Group on Endoscopic Ultrasound Guided Biliary Drainage
Abstract Background It is unclear whether the insertion of an axis-orienting double-pigtail plastic stent (DPS) through biliary lumen-apposing meal stent (LAMS) in EUS-guided choledochoduodenostomy (CDS) improves the stent patency. The aim of this study is to determine whether this technical variant offers a clinical benefit in EUS-guided biliary drainage (BD) for the management of distal malignant biliary obstruction. Methods/design This is a multicenter open-label, randomized controlled trial with two parallel groups. Eighty-four patients with malignant biliary obstruction will undergo EUS-BD (CDS type) using LAMS in 7 tertiary hospitals in Spain and will be randomized to the LAMS and LAMS plus DPS groups. The primary endpoint is the rate of recurrent biliary obstruction, as a stent dysfunction parameter, detected during follow-up. Secondary endpoints: technical and clinical success (reduction in bilirubin > 50% within 14 days of stent placement), safety, and others (number of reinterventions, time to biliary obstruction, prognostic factors, survival rate). Discussion The BAMPI trial has been designed to determine whether the addition of a coaxial axis-orienting DPS through LAMS is superior to LAMS alone to prevent stent dysfunction. Trial registration ClinicalTrials.gov NCT04595058 . Registered on October 14, 2020.